Inovio Pharmaceuticals
INO
#9403
Rank
S$85.47 M
Marketcap
$2.19
Share price
-5.78%
Change (1 day)
-87.62%
Change (1 year)

Revenue for Inovio Pharmaceuticals (INO)

Revenue in 2024 (TTM): S$0.29 Million

According to Inovio Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is S$0.29 Million. a decrease over the revenue in the year 2023 that were of S$1.09 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Inovio Pharmaceuticals from 1999 to 2024

20002005201020152020$10M$20M$30M$40M$50M$60Mcompaniesmarketcap.com

Annual revenue

Year Revenue Change
2024 S$0.29 M-73.06%
2023 S$1.09 M-92.01%
2022 S$13.75 M473.4%
2021 S$2.39 M-75.53%
2020 S$9.8 M76.86%
2019 S$5.54 M-86.69%
2018 S$41.64 M-26.26%
2017 S$56.46 M10.32%
2016 S$51.18 M-10.81%
2015 S$57.39 M315.36%
2014 S$13.81 M-19.02%
2013 S$17.06 M238.77%
2012 S$5.03 M-60.3%
2011 S$12.68 M60.27%
2010 S$7.91 M-38.18%
2009 S$12.8 M326.82%
2008 S$2.99 M-56.64%
2007 S$6.91 M30.09%
2006 S$5.31 M-41.58%
2005 S$9.1 M378.1%
2004 S$1.9 M1291.63%
2003 S$0.13 M-58.39%
2002 S$0.32 M
2000 S$9.64 M-34.16%
1999 S$14.65 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
S$85.46 B 29,218,842.30%๐Ÿ‡บ๐Ÿ‡ธ USA
S$119.31 B 40,789,131.98%๐Ÿ‡บ๐Ÿ‡ธ USA
S$3.35 M 1,048.07%๐Ÿ‡บ๐Ÿ‡ธ USA
S$69.47 B 23,752,173.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$86.19 B 29,467,744.74%๐Ÿ‡บ๐Ÿ‡ธ USA
S$53.97 B 18,452,000.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$38.62 B 13,204,128.59%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.84 M 190.16%๐Ÿ‡บ๐Ÿ‡ธ USA